Health Economics & Analysis in Clinical Development

Crown, William H.; Marshall, Deborah; Barr, Charles E.
February 2007
Applied Clinical Trials;Feb2007, Vol. 16 Issue 2, p44
Academic Journal
The article reports on the role of health data in drug development as the U.S. pharmaceutical industry faces serious financial challenges. It has been noted that pharmaceutical companies is rethinking new drug developments and marketing strategies in response to a health care system that is moving towards a consumer-directed care model. The industry is designing studies of health economic and patient-reported outcomes to give consumers with evidence of the economic value of their products.


Related Articles

  • HARD OF (AD) HERING. Koroneos, George // Pharmaceutical Executive;Aug2008, Vol. 29 Issue 8, p42 

    The article focuses on the efforts by pharmaceutical companies in the U.S. in implementing technologies and programs to help patients adhere to their drug regimens. Reminder messaging, nurse services and disease-state compliance programs are at the top of the companies' list of compliance...

  • DATA MINING. Crown, William H. // Pharmaceutical Executive;Sep2007, Vol. 27 Issue 9, p124 

    The article focuses on maximizing a new drug's cost-effectiveness. Health economics and data mining is important to drug manufacturers in showing the value of a new drug. Pharmaceutical companies use health economics in modeling cost-effectiveness to payers. However, database analyses are...

  • The Future of Clinical Diagnostics. Santicerma, Anthony J.; Engelhart, Mark M.; Harvey, Michael H. // Applied Clinical Trials;Oct2004 Supplement, Vol. 13, p6 

    Focuses on the change in the drug development approaches and marketing strategy by pharmaceutical companies in the U.S. Impetus to the changes; Implications of generic drugs for the industry; Citations of the trends affecting the clinical diagnostics business.

  • Research & Markets: The Outlook for Pharmaceuticals Worldwide.  // Biomedical Market Newsletter;1/21/2012, Vol. 21, p1 

    The article informs that Research & Markets Ltd. has announced the inclusion of the report "The Outlook for Pharmaceuticals Worldwide" to their offering. It provides critical business insights to the prospects for, and risks in, leading pharmaceutical markets. It indicates that South Korea,...

  • Editorial. Lerer, Leonard // Journal of Medical Marketing;Jun2007, Vol. 7 Issue 3, p183 

    The author reflects on the influence of the internet in medical marketing. In his review of the state of digital technologies in the pharmaceutical industry, he was able to identify the areas where the internet was changing sales and marketing processes, especially when it came to interaction...

  • Using a 360° view of customers for segmentation. Khandelwal, Sushant; Mathias, Ashwin // Journal of Medical Marketing;Aug2011, Vol. 11 Issue 3, p215 

    The pharmaceutical industry is faced with a challenging business environment, a changing marketplace, and evolving customer landscape. Sales and marketing are developing new novel methods to segment customers, and develop sales and marketing strategies to improve sales and profitability. A...

  • Size (and structure) matters. Reicheg, Alan // Pharmaceutical Representative;Jul2008, Vol. 13 Issue 7, p24 

    The article reports that the U.S. pharmaceutical industry marketers combine advanced analytics with the knowledge and expertise of regional sales representatives to enhance their productivity. It notes that advanced analytics create new opportunities without disrupting sales and marketing plans....

  • RULE OF THE TOOL. Thomson, Ross // Medical Marketing & Media;Apr2008, Vol. 43 Issue 4, p56 

    The author relates the logic of an expression, the rule of the tool, to the marketing strategy of the pharmaceutical industry. He explains that the rule of the tool talks about a person who believes that every task seem to be completed using a screwdriver, even when it is the wrong tool. He also...

  • Tomorrow's Changes Today. Myers, Kelly D. // Pharmaceutical Executive;Jan2007, Vol. 27 Issue 1, p79 

    The article discusses the significance of advanced analytical tools for targeted product launches in the pharmaceutical industry in the U.S. They are particularly valuable in identifying key patterns in complex data flows and help companies figure out how to deliver the right message to the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics